Organism Engineering Related News

Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids

Leading Companies from Emerging Industries Join Forces to Efficiently Produce High-Purity Cannabinoids at Scale BOSTON and TORONTO, Sept. 4, 2018 /PRNewswire/ - Today, Cronos Group Inc. (NASDAQ : CRON ) (TSX: CRON) ("Cronos Group"), a geographically diversified and vertically integrated cannabis [...]

Manus Bio Raises $19.4 million Series A Financing to Accelerate Product Commercialization and Expands Board of Directors

CAMBRIDGE, Mass., July 03, 2018 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a supplier of natural ingredients, announced today that it has raised $19.4 million through the issuance of Series A Preferred Shares to accelerate commercialization of its [...]

Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease

Company’s multiple contracts with a total $64M ceiling with IARPA, DoD, and DHS establish integrated platform to enable the responsible growth of synthetic biology and its application in health and biosecurity BOSTON, June 27, 2018 /PRNewswire/ -- Ginkgo Bioworks, the organism [...]

Amyris Announces Signing of Major UCP in Porto/AICEP Consortium Project Agreement Valued at $50 Million

EMERYVILLE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and [...]

Ginkgo Bioworks Marks 10-Year Anniversary with iGEM Partnership

New collaboration reflects Ginkgo Bioworks' iGEM roots and celebrates the future of synthetic biology BOSTON, June 14, 2018 /PRNewswire/ -- Today, Ginkgo Bioworks, the organism design company, announced its commitment as a lead partner of the 2018 International Genetically Engineered Machine [...]

Biosyntia raises €4 million in Series A financing to advance its microbe engineering technology and bio-based product pipeline

Biosyntia has today announced a Series A investment in the company of 4 million euros from Sofinnova Partners, a new investor, and Novo Seeds, an existing investor. The investment will allow the company continued developments of its lead products and [...]